Drug Companies Set High Prices for HIV Treatment (2002)

Patents and Patients: US pharmaceutical companies are more interested in protecting their valuable drugs patents than treating Indian AIDS sufferers.

Subscribe to Journeyman here: http://www.youtube.com/subscription_center?add_user=journeymanpictures

Dr Hamied works for CILPA, an Indian drug company that develops medicines for HIV sufferers. He aims to make treatment affordable for India’s poor. Yet he has been accused by multi-nationals pharmaceutical firms of ‘theft.’ “Patents are vital to protecting the development of new drugs.” claims Dr. Raaijmakers. Dr Hamied counters this though, stating; “Companies spend twice as much marketing their products, rather than developing them.” To make matters worse, few people understand how to effectively take Hamied’s drugs, creating the possibility of drug resistant strains of HIV.

For more information, visit https://www.journeyman.tv/film/2039

Like us on Facebook: https://www.facebook.com/journeymanpictures
Follow us on Twitter:
https://twitter.com/JourneymanNews
https://twitter.com/JourneymanVOD
Follow us on Instagram: https://instagram.com/journeymanpictures
Visit our subreddit: https://www.reddit.com/r/JourneymanPictures/

TVE – Ref. 2039

Leave your comment